Surgical Oncologist
The Netherlands Cancer Institute, Netherlands
Winan van Houdt is a surgical oncologist/scientist in The Netherlands Cancer Institute in Amsterdam, treating mainly soft tissue sarcoma and melanoma/advanced skin cancer patients. He obtained his medical degree (MD) and a master of science (MS) in pharmaceutical science at Utrecht University, the Netherlands. He did his PhD in the lab of experimental and surgical oncology at University Medical Center Utrecht about targeting colorectal liver metastases. He subsequently trained as a general surgeon in hospitals in Utrecht and Amsterdam, the Netherlands, after which he did a surgical oncology fellowship focusing on sarcoma in Milan, Toronto and New York. After his fellowship, he was a consultant in the sarcoma and melanoma unit in the Royal Marsden, London, UK. In 2017 he went to the sarcoma and melanoma unit of The Netherlands Cancer Institute, where he recently received a grant from the Dutch Cancer Foundation to start a translational research program for sarcoma. Dr. Van Houdt is the secretary of the EORTC soft tissue and bone sarcoma study group since 2019. He is involved in many clinical and translational national and international research collaborations, including the EORTC STRASS2 study examining the role of neo-adjuvant chemotherapy in retroperitoneal sarcoma.